I-131 Metaiodobenzylguanidine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for I-131 Metaiodobenzylguanidine, covering 2018-10-31 to 2018-10-31. Get the full timeline:
Most recent: Clinical Trial Update: High Dose I-131 Metaiodobenzylguanidine(MIBG) for Metastatic Neuroendocrine Tumors [Phase 3]